IGC PHARMA, INC. (IGC) scores 14 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 0.03, representing a 89% premium to fair value. Quantitative score: 30/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.